Publications


Iontophoresis-coupled rapidly dissolving polymeric microneedle patch of naloxone for its enhanced transdermal delivery;
Tijani, AO, Connors, D, Schiavone, C, Peláez, MJ, Dogra, P & Puri, A 2024, , International Journal of Pharmaceutics, vol. 660, pp. 124289. https://doi.org/10.1016/j.ijpharm.2024.124289

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer;
Dogra, P, Shinglot, V, Ruiz-Ramírez, J, Cave, J, Butner, JD, Schiavone, C, Duda, DG, Kaseb, AO, Chung, C, Koay, EJ, Cristini, V, Ozpolat, B, Calin, GA & Wang, Z 2024, , medRxiv. https://doi.org/10.1101/2024.03.14.24304306

Hybrid Cellular Automata Modeling Reveals the Effects of Glucose Gradients on Tumour Spheroid Growth;
Messina, L, Ferraro, R, Peláez, MJ, Wang, Z, Cristini, V, Dogra, P & Caserta, S 2023, , Cancers, vol. 15, no. 23, 5660. https://doi.org/10.3390/cancers15235660

Hybrid Cellular Automata Modeling Reveals the Effects of Glucose Gradients on Tumour Spheroid Growth;
Messina, L, Ferraro, R, Peláez, MJ, Wang, Z, Cristini, V, Dogra, P & Caserta, S 2023, , Cancers, vol. 15, no. 23, 5660. https://doi.org/10.3390/cancers15235660

Using mechanistic model of the vaccine-induced immune response to identify optimal administration strategies.;
Schiavone , C, Caserta, S & Dogra, P 2023, , Research Day, University of Naples, Naples Italy, Naples, Italy, 11/24/23 - 11/24/23.

Machine learning-based rational design of nanoparticles for improved safety in biomedical applications.;
Cave, J, Wang, Z, Cristini, V & Dogra, P 2023, , Physiology, Biophysics and Systems Biology Annual Retreat, Weill Cornell Graduate School of Medicine, New York, United States, 11/2/23 - 11/2/23.

Exploring Cell Migration Mechanisms in Cancer: From Wound Healing Assays to Cellular Automata Models;
Migliaccio, G, Ferraro, R, Wang, Z, Cristini, V, Dogra, P & Caserta, S 2023, , Cancers, vol. 15, no. 21, 5284. https://doi.org/10.3390/cancers15215284

Multiscale Modeling-Identified Synergistic Combinations of Anti-microRNA-155 and Standard-of-Care Drugs for Improved Outcomes in Non-small Cell Lung Cancer;
Dogra, P, Cave, J, Butner, J, Cristini, V & Wang, Z 2023, , American Association of Pharmaceutical Scientists PharmSci 360 Conference 2023, Orlando, United States, 10/22/23 - 10/25/23.